Genoray제노레이
122310 · KOSDAQ · ₩122310 · 제노레이
- Market cap
- ₩45B
- Enterprise value
- ₩57B
- P/E
- 17.3×
- P/B
- 0.6×
- Dividend yield
- 4.8%
- ROE
- 3.2%
- Net margin
- 2.4%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−41.0% from the high
₩3,035Today: ₩3,035 – ₩3,120₩5,250
Returns
- 1W−1.7%
- 1M−7.1%
- 3M−10.3%
- 6M−32.7%
- YTD−25.6%
- 1Y−38.1%
- Volume today
- 5,823
- 0.9× the 20-day average
- Traded today
- ₩18M
- Listed shares
- 14,553,844
- EPS (12 months)
- ₩179
- Earnings yield 5.8%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 43 of 100 (50 is a normal day for this stock).
- MomentumWeak-8.6% over the last month; the price is below its 20-day average.
- News impactLow2 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
Genoray stock overview
Genoray (제노레이, KRX: 122310) is listed on KOSDAQ, in the Medical & precision devices sector. The company researches, develops, manufactures and sells X-ray imaging diagnostic equipment used in hospitals and dental clinics. Its shares closed at ₩3,095 on Oct 27, 2026, down 0.32% on the day, giving it a market value of ₩45B.
Key facts
- Market cap
- ₩45B
- Sector
- Medical & precision devices
- Latest price change
- −0.32%
- As of
- Oct 27, 2026
- Main business
- The company researches, develops, manufactures and sells X-ray imaging diagnostic equipment used in hospitals and dental clinics.
Quick answers about Genoray
- What does Genoray do?
- The company researches, develops, manufactures and sells X-ray imaging diagnostic equipment used in hospitals and dental clinics. Its Medical division offers C-arm and mammography systems for hospitals, while its Dental division offers CT and panoramic systems for dental clinics, and it operates in both segments in Korea.
- What is the market cap of Genoray?
- The market capitalisation of Genoray was ₩45B at the close on Oct 27, 2026.
- Who are the largest shareholders of Genoray?
- According to the latest official filings, the largest reported holders are Park Byeong-uk (24.31%, as of Oct 28, 2026); Orion Asset Management (6.43%, as of Jan 30, 2026); An Jae-min (0.46%, as of Aug 28, 2026).
- When is the next earnings report from Genoray?
- Korean companies rarely announce results dates in advance. Based on when Genoray filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
- Does the National Pension Service own Genoray?
- Yes. The National Pension Service held 0.20% of Genoray shares as of Dec 31, 2019.
Company profile
The company researches, develops, manufactures and sells X-ray imaging diagnostic equipment used in hospitals and dental clinics. Its Medical division offers C-arm and mammography systems for hospitals, while its Dental division offers CT and panoramic systems for dental clinics, and it operates in both segments in Korea.
Written by AI from the company's latest annual report.
- Korean name
- 제노레이
- CEO
- 박병욱
- Founded
- Apr 2001
- Listed
- May 2018
- Listed shares
- 14,553,844
- Fiscal year ends
- Month 12
- Website
- www.genoray.com
Similar companies
- TSE131290 · ₩2.9T₩260,000+7.88%
- Kctech281820 · ₩1.8T₩91,900+6.37%
- Classys214150 · ₩1.7T₩26,500−2.57%
- Park Systems140860 · ₩1.6T₩225,500+1.12%
- Curiox Biosystems445680 · ₩1.1T₩62,300+6.13%
- DI003160 · ₩1.1T₩37,800+4.71%
- Seers458870 · ₩1T₩26,300−5.57%
- LivsMed491000 · ₩937B₩37,100+1.50%
Recent filings
See all- Insider shareholding reportOct 28, 2026
- 5%+ holding reportOct 22, 2026
- Cash dividend decisionOct 1, 2026
- Interim (Quarterly) Dividend Ex-DateSep 28, 2026
- 5%+ holding reportSep 16, 2026
Titles in Korean until English translations are added.
Also known as: Genoray / 제노레이 / 122310 / KRX:122310
Source: KRX statistical information